Research and Development Authority

The vision of Shaare Zedek Medical Center includes the goal of advancing medical research. We are committed to forging new paths for treating patients and actively encouraging our staff to lead, collaborate and participate in research efforts in Israel and beyond.

Research and development at Shaare Zedek Medical Center is experiencing an unprecedented growth phase. The number of articles published by Shaare Zedek researchers is steadily increasing year after year. Currently, there are around 1,000 ongoing research projects within the hospital, with approximately 400 new studies submitted for approval to the Institutional Review Board (IRB) annually. The number of companies engaged in collaborations with Shaare Zedek reached 300 in the year 2022. The research activity is seamlessly integrated into the hospital's ongoing operations, aiming to refine and enhance the medical landscape.

The Innovation Center embodies Shaare Zedek's strength in all aspects related to medical information access, digitization, and the collection and analysis of data duplicates. Its collaborative reach is extensive, encompassing startups and large Israeli and global companies. For instance, in a joint project with Google, Meda'it's Innovation Center is advancing the development of an AI-supported decision-making algorithm for physicians in the fields of gastroenterology and surgery. Additional deep collaborations are taking place with other major companies like Sight, MedM, and more.

Concurrently, approximately 1,000 research studies are being conducted at Shaare Zedek on a wide range of topics in collaboration with hundreds of companies and organizations. In 2022 alone, over 400 new requests for approval of medical research studies were submitted to the Institutional Review Board, with more than half of them initiated by the industry.

Meda'it's Technology Transfer Office (TTO) leads the development of inventions and application ideas arising from Shaare Zedek's medical team, with the goal of enhancing medical treatment. It operates as a full-fledged and internal accelerator. The unit guides the process from idea conception, patent filing, partner identification, creating a prototype, to fundraising for project advancement. Meda'it invests initial funding in ideas that have passed Shaare Zedek's patent committee, aiming to bring the idea to an appropriate stage for attracting investors, entering an incubator, or establishing subsidiary companies.